泰凌医药(01011.HK)联营康辰生物科技可能进行资产分拆

阿斯达克财经
May 12, 2025

泰凌医药(01011.HK) 公布,收到联营康辰生物科技通知,其大股东康辰药业(603590.SH) 提出对康辰生物科技之资产进行分拆,解散联营关系,各自独立经营。其中,划分涉及康辰生物科技的主要资产-密盖息针剂与喷剂;及公司可以根据价格和需要优先选择划分后的资产。近期公司将与联营公司股东开会讨论商议此事。(de/d)(港股报价延迟最少十五分钟。) (A股报价延迟最少十五分钟。)AASTOCKS...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10